HAYLIE WETZEL: Open Payments
NPI 1912684531 · BISMARCK, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$661 in 39 payments from 12 companies in 2025. Trend: 2023 $325 · 2024 $813 · 2025 $661
Food & beverage: $661
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 16 | $206 |
| Amgen Inc. | 6 | $106 |
| E.R. Squibb & Sons, L.L.C. | 2 | $76 |
| PFIZER INC. | 4 | $75 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| LeMaitre Vascular, Inc. | 1 | $33 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $32 |
| Merck Sharp & Dohme LLC | 2 | $28 |
| Actelion Pharmaceuticals US, Inc. | 1 | $19 |
| Alnylam Pharmaceuticals Inc. | 1 | $18 |
Products named: LEQVIO, REPATHA, CAMZYOS, ELIQUIS, WAINUA, HYDRO LEMAITRE VALVULOTOME, JARDIANCE, VERQUVO.
Industry payments across ND — which companies pay providers there.
